[1]钱尧轩,庄敏杰,周志杰,等.硬通道穿刺引流术联合脑膜中动脉栓塞治疗合并高危复发因素的慢性硬膜下血肿[J].中国临床神经外科杂志,2024,29(11):655-659664.[doi:10.13798/j.issn.1009-153X.2024.11.004]
　QIAN Yao-xuan,ZHUANG Min-jie,ZHOU Zhi-jie,et al.Safety and effectiveness of hard channel puncture and drainage combined with middle meningeal artery embolization for chronic subdural hema-tomas with high-risk recurrence factors[J].,2024,29(11):655-659664.[doi:10.13798/j.issn.1009-153X.2024.11.004]
点击复制

硬通道穿刺引流术联合脑膜中动脉栓塞治疗合并高危复发因素的慢性硬膜下血肿()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
29
期数:
2024年11期
页码:
655-659664
栏目:
论著
出版日期:
2024-11-30

文章信息/Info

Title:
Safety and effectiveness of hard channel puncture and drainage combined with middle meningeal artery embolization for chronic subdural hema-tomas with high-risk recurrence factors
文章编号:
1009-153X（2024）11-0655-05
作者:
钱尧轩; 庄敏杰; 周志杰; 彭玮; 闫西刚
215128江苏，苏州市吴中人民医院神经外科（钱尧轩、庄敏杰、周志杰、彭玮、闫西刚）
Author(s):
QIAN Yao-xuan;  ZHUANG Min-jie;  ZHOU Zhi-jie;  PENG Wei;  YAN Xi-gang
Department of Neurosurgery, The People's Hospital of Wuzhong, Suzhou 215128, China
关键词:
慢性硬膜下血肿; 脑膜中动脉栓塞; 硬通道穿刺引流术; 安全性; 有效性
Keywords:
Chronic subdural hematoma;  High-risk recurrence factors;  Middle meningeal artery;  Embolization;  Hard-channel puncture and drainage;  Safety;  Efficacy
分类号:
R 651.1+5; R 651.1+1
DOI:
10.13798/j.issn.1009-153X.2024.11.004
文献标志码:
A
摘要:
目的 探讨硬通道穿刺引流术联合脑膜中动脉（MMA）栓塞治疗含高危复发因素的慢性硬膜下血肿（CSDH）的安全性及有效性。方法 回顾性分析2021年1月至2023年4月手术治疗的22例含高危复发因素的CSDH的临床资料。所有病人均采用硬通道穿刺引流术联合MMA栓塞治疗。结果 栓塞方法：单纯EVAL胶栓塞13例，单纯弹簧圈栓塞2例，EVAL胶联合弹簧圈栓塞7例；双侧栓塞9例。术后CT复查显示血肿腔内密度增高9例。所有病人术后临床症状均缓解。22例术后随访3个月未见血肿进展、复发。结论 硬通道穿刺引流术联合MMA栓塞是治疗CSDH的有效手段之一，远期疗效有待进一步观察。
Abstract:
Objective To investigate the safety and efficacy of hard-channel puncture and drainage combined with middle meningeal artery (MMA) embolization for chronic subdural hematomas (CSDHs) with high-risk recurrence factors. Methods The clinical data of 22 patients with CSDHs associated with high-risk recurrence factors who underwent hard-channel puncture and drainage combined with MMA embolization from January 2021 to April 2023 were retrospectively analyzed. Results Regarding the embolization methods, 13 patients received pure EVAL glue embolization, 2 received pure coil embolization, and 7 received a combination of EVAL glue and coil embolization; among them, 9 patients underwent bilateral embolization. Postoperative CT reexamination indicated that the density within the hematoma cavity increased in 9 patients. All patients' clinical symptoms were alleviated after the operation. No hematoma progression or recurrence was observed during the 3-month follow-up. Conclusion Hard-channel puncture and drainage combined with MMA embolization is one of the effective approaches for treating CSDH associated with high-risk recurrence factors, but its long-term therapeutic effect still requires further observation.

参考文献/References:

[1] FEGHALI J, YANG W, HUANG J. Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome [J]. World Neurosurg, 2020, 141: 339-345.
[2] YANG F, XU ZG, CHEN HX, et al. Analysis of risk factors of the evolution of subdural hygroma into chronic subdural hematoma [J]. Modern Chin Doc, 2023, 61(1): 19-22. 杨　帆，许志剑，陈华辉，等. 硬膜下积液演变为慢性硬膜下血肿相关危险因素研究[J]. 中国现代医生，2023，61（1）：19-22.
[3] FANTONI M, ELIEZER M, SERRANO F, et al. High frequency of ophthalmic origin of the middle meningeal artery in chronic subdural hematoma [J]. Neuroradiology, 2020, 62(5): 639-644.
[4] GONG K, RUAN SY, YAN KX, et al. Post-operative recurrence factors of septated chronic subdural hematoma：a retrospective analysis [J]. Chin J Neurosurg Dis Res, 2018, 17(5): 439-442. 龚　凯，阮士艳，闫凯旋，等. 分隔型慢性硬膜下血肿术后复发因素回顾分析[J]. 中华神经外科疾病研究杂志，2018，17（5）：439-442.
[5] WANG MX, BAI MM. Research progress of surgical treatment of chronic subdural hematoma [J]. Adv Clin Med, 2021, 11(12): 5917-5921. 王明行，白茫茫. 慢性硬膜下血肿的手术治疗研究进展[J]. 临床医学进展，2021，11（12）：5917-5921.
[6] STANISIC M, PRIPP AH. A reliable grading system for prediction of chronic subdural hematoma recurrence requiring reoperation after initial burr-hole surgery [J]. Neurosurgery, 2017, 81(5): 752-760.
[7] WU W, ZHANG HZ, YAN ZC, et al. Prognostic factors analysis of chronic subdural hematoma(report of 214 cases) [J]. J Clin Neurosurg, 2012, 9(6): 327-330. 吴　巍 ，张恒柱，严正村，等. 慢性硬膜下血肿的预后影响因素分析（附214例报告）[J]. 临床神经外科杂志，2012，9（6）：327-330 [8] TORIHASHI K, SADAMASA N, YOSHIDA K, et al. Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases [J]. Neurosurgery, 2008, 63(6): 1125-1129.
[9] BAN SP, HWAANG G, BYOUN HS, et al. Middle meningeal artery embolization for chronic subdural hematoma [J]. Radiology, 2018, 286(3): 992-999.
[10] SUN QH, LI ZY, SUN JJ, et al. Progress in the clinical application of middle meningeal artery embolizationin the treatment of chronic subdural hematoma [J]. Med J NDFNC, 2021, 42(7): 725-729. 孙启皓，荔志云，孙建军，等. 脑膜中动脉栓塞治疗慢性硬膜下血肿的临床应用研究进展[J]. 西北国防医学杂志，2021，42（7）：725-729.
[11] SZCZYGIELSKI J, GUND SM, SCHWERDTFEGER K, et al. Factors affecting outcome in treatment of chronic subdural hematoma in ICU patients: impact of anticoagulation [J]. World Neurosurg, 2016, 92: 426-433.
[12] CATAPANO JS, DUCRUET AF, NGUYEN CL, et al. Middle meningeal artery embolization for chronic subdural hematoma: an institutional technical analysis [J]. J Neurointerv Surg, 2021, 13(7): 657-660.
[13] MARTINEZ JL, DOMINGO RA, SATTRU M, et al. The middle meningeal artery: branches, dangerous anastomoses, and implications in neurosurgery and neuroendovascular surgery [J]. Oper Neurosurg (Hagerstown), 2022, 22(1): 1-13.
[14] KAN P, MARAGKOS GA, SRIVATSAN S, et al. Middle meningeal artery embolization for chronic subdural hematoma: a multi-center experience of 154 consecutive embolizations [J]. Neurosurgery, 2021, 88(2): 268-277.
[15] EL KIM. Embolization therapy for refractory hemorrhage in patients with chronic subdural hematomas [J]. World Neurosurg, 2017, 101: 520-527.
[16] IRONSIDE N, NGUYEN C, DO Q, et al. Middle meningeal artery embolization for chronic subdural hematoma: a systematic review and meta-analysis [J]. J Neurointerv Surg, 2021, 13(10): 951-957.
[17] LIU XY, WEI Y, XIA XH, et al. A meta-analysis of middle meningeal artery embolization for refractory chronic subdural hematoma [J]. J Clin Neurosurg, 2022, 19(1): 91-95. 刘笑言，魏　懿，夏小辉，等. 脑膜中动脉栓塞治疗难治疗性慢性硬膜下血肿的Meta分析[J]. 临床神经外科杂志，2022，19（1）：91-95.

相似文献/References:

[1]庞陆军　张恒柱　李育平　严正村　王杏东　魏　民.慢性硬膜下血肿术前影像学分型和手术治疗[J].中国临床神经外科杂志,2016,(02):101.[doi:10.13798/j.issn.1009-153X.2016.02.014]
[2]王林风　郑华山　操　廉　李庆阳　贾俊峰　丁　磊　张　武.钻孔引流术治疗慢性硬膜下血肿90例[J].中国临床神经外科杂志,2016,(02):109.[doi:10.13798/j.issn.1009-153X.2016.02.018]
[3]王　斌　杨秀莹.高位颅骨钻孔引流术治疗慢性硬膜下血肿[J].中国临床神经外科杂志,2016,(02):115.[doi:10.13798/j.issn.1009-153X.2016.02.021]
[4]孙成法　姜　华　褚荣涛　金　科.671例慢性硬膜下血肿的临床分析[J].中国临床神经外科杂志,2016,(01):42.[doi:10.13798/j.issn.1009-153X.2016.01.015]
[5]陈　新　张传玲　王伟功.锥颅引流术与钻孔冲洗引流术治疗慢性硬膜下血肿的疗效对比分析[J].中国临床神经外科杂志,2016,(01):53.[doi:10.13798/j.issn.1009-153X.2016.01.020]
[6]黄海源　颜庆华　张　猛　丁兴进　刘　枫　沈建华　史　俊.慢性硬膜下血肿钻孔引流术中持续冲洗的临床效果[J].中国临床神经外科杂志,2016,(01):55.[doi:10.13798/j.issn.1009-153X.2016.01.021]
[7]曾昭戎.慢性硬膜下血肿钻孔引流术中尿激酶的应用体会[J].中国临床神经外科杂志,2015,(08):491.[doi:10.13798/j.issn.1009-153X.2015.08.017]
[8]李乾锋　吴京雷　杨国平.神经内镜手术治疗慢性硬膜下血肿50例[J].中国临床神经外科杂志,2015,(09):557.[doi:10.13798/j.issn.1009-153X.2015.09.017]
[9]江敦清　宋熙文　陈世文.IL-6和VEGF在慢性硬膜下血肿中的检测及意义[J].中国临床神经外科杂志,2015,(05):287.[doi:10.13798/j.issn.1009-153X.2015.05.010]
　JIANG Dun-qing,SONG Xi-wen,CHEN Shi-wen..Detection of IL-6 and VEGF levels in chronic subdural hematomas and their meanings[J].,2015,(11):287.[doi:10.13798/j.issn.1009-153X.2015.05.010]
[10]盖延廷　贺子建.钻孔引流术与钻孔冲洗术治疗慢性硬膜下血肿疗效的Meta分析[J].中国临床神经外科杂志,2015,(05):293.[doi:10.13798/j.issn.1009-153X.2015.05.012]
[11]黄伟,潘起航,马钊,等.脑膜中动脉栓塞治疗慢性硬膜下血肿的疗效[J].中国临床神经外科杂志,2024,29(08):462.[doi:10.13798/j.issn.1009-153X.2024.08.004]
　HUANG Wei,PAN Qi-hang,MA Zhao,et al.Efficacy of embolization of the middle meningeal artery for patients with chronic subdural hematomas[J].,2024,29(11):462.[doi:10.13798/j.issn.1009-153X.2024.08.004]

备注/Memo

备注/Memo:
（2023-08-08收稿，2024-10-21修回）
通信作者：闫西刚，Email：yanxg1980@163.com
更新日期/Last Update: 2024-11-30